ARCHIVES

NCI selects nanotech centers for funding.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Unique Molecular Profile For Lung Cancer Described

March 31, 2006

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

Healy’s “Save Bob” Campaign

January 6, 1995

Cancer Society, With Level Budget, Cuts On More Money to Fund “Pay Ifs” In FY92

March 27, 1992